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Antidepressant drugs are usually administered for several weeks for the treatment
of major depressive disorder. However, they are also prescribed in several
additional psychiatric conditions as well as during long-term maintenance treatments.
Antidepressants induce adaptive changes in several forebrain structures which
include modifications at glutamatergic synapses. We recently found that repetitive
administration of the selective serotonin reuptake inhibitor (SSRI) fluoxetine to naïve
adult male rats induced an increase of mature, mushroom-type dendritic spines in
several forebrain regions. This was associated with an increase of GluA2-containing
α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors (AMPA-Rs) in telencephalic
postsynaptic densities. To unravel the functional significance of such a synaptic
re-arrangement, we focused on glutamate neurotransmission in the hippocampus. We
evaluated the effect of four weeks of 0.7mg/kg fluoxetine on long-term potentiation
(LTP) and long-term depression (LTD) in the CA1 hippocampal subfield. Recordings in
hippocampal slices revealed profound deficits in LTP and LTD at Schaffer collateral-CA1
synapses associated to increased spine density and enhanced presence of mushroom-
type spines, as revealed by Golgi staining. However, the same treatment had neither
an effect on spine morphology, nor on LTP and LTD at perforant path-CA1 synapses.
Cobalt staining and immunohistochemical experiments revealed decreased AMPA-R Ca2+
permeability in the stratum radiatum (s.r.) together with increased GluA2-containing
Ca2+ impermeable AMPA-Rs. Therefore, 4 weeks of fluoxetine treatment promoted
structural and functional adaptations in CA1 neurons in a pathway-specific manner that
were selectively associated with impairment of activity-dependent plasticity at Schaffer
collateral-CA1 synapses.
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INTRODUCTION
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that
is widely used to treat anxiety- and mood-related disorders,
but in addition, its use has been expanded to other psychiatric
conditions and is often continued after remission of symptoms
(Schatzberg, 2000; Blier et al., 2007). The therapeutic effect of
antidepressant drugs is mediated by cellular events which include
adult hippocampal neurogenesis, maturation of nascent neu-
rons and changes in gene expression. It has been shown that
the activation of gene transcription following fluoxetine treat-
ment is elicited by epigenetic remodeling of chromatin structure
leading to increased plasticity and dendritic spine remodeling
(Maya Vetencourt et al., 2011; Wang et al., 2011). This has
been proposed to underlie plastic changes in glutamate neuro-
transmission (Pittenger and Duman, 2008; Sanacora et al., 2008;
Maya-Vetencourt et al., 2012).
It had been previously described by us that 28 days of
0.7mg/kg fluoxetine administration to adult naïve rats induced
growth of dendritic spines and changes in glutamate receptor
subunit composition in cerebrocortical synapses (Ampuero et al.,
2010). In addition, such changes led to impairment of remote, but
not recent, hippocampus-dependent memory (Ampuero et al.,
2013). To study the effect of fluoxetine on cellular plasticity, we
focused on CA1 pyramidal neurons which receive spatially seg-
regated direct and indirect excitatory inputs from the entorhinal
cortex (EC) via the perforant path and the Schaffer collaterals
originating in CA3, respectively. While Schaffer collaterals termi-
nate in the CA1 stratum radiatum (s.r.) on proximal dendrites,
the direct perforant path makes synapses on the distal dendrites
of CA1 neurons that are localized in the stratum lacunosum
moleculare (s.l.m.) (Steward, 1976).
The induction of long-term potentiation (LTP) and long-term
depression (LTD) of excitatory synaptic transmission at CA1
requires both N-methyl-D-aspartate receptor (NMDA-R) acti-
vation and trafficking of α-amino-3-hydroxy-5-methylisoxazole-
4-propionate receptors (AMPA-Rs) (Citri and Malenka, 2008).
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NMDA-Rs are heterotetramers composed mandatorily of two
GluN1 and two GluN2 subunit types (A to D), whereas AMPA-
Rs are comprised of four unique subunits, GluA1-GluA4. In
the adult hippocampus, AMPA-Rs are heterotetramers assem-
bled preferentially by GluA1 and GluA2/GluA3 subunits. Subunit
composition is a major determinant of biophysical channel prop-
erties, downstream signaling, receptor trafficking and synaptic
plasticity. In such a way, GluA2-containing receptors are Ca2+
impermeable, in contrast to GluA2-lacking channels that are per-
meable to the divalent ion (Traynelis et al., 2010). High frequency
synaptic stimulation induces LTP via NMDA-R-dependent Ca2+
influx, activation of several protein kinases and recruitment
of GluA1-containing AMPA-Rs to the synapse. In contrast,
LTD is induced by low frequency synaptic stimulation, pro-
longed increases in calcium levels leading to protein phosphatase
activation and GluA1- and GluA2-containing AMPA-R inter-
nalization (Derkach et al., 2007; Isaac et al., 2007; Citri and
Malenka, 2008). Although the contribution of specific AMPA-
R subunits is not firmly established for LTD, GluA1 subunits
at least play an important role (Meng et al., 2003; He et al.,
2011). Additionally, LTP and LTD are accompanied by oppos-
ing changes in spine density and morphology, i.e., spine length,
head volume, and neck diameter. As such, LTP correlates with
growth of new spines and enlargement of preexisting spines
whereas LTD associates with shrinkage and loss of spines (Segal,
2005).
Based on the fluoxetine-induced enrichment of GluN2A
over GluN2B-containing NMDA-Rs and GluA2 over GluA1-
containing AMPA-Rs (Ampuero et al., 2010) associated to
increased mushroom-type spines, we hypothesized that such
changes might negatively affect further potentiation. Therefore,
we examined the consequences of repetitive fluoxetine treatment
on spine morphology as well as LTP and LTD in the proximal
and distal dendrites within the CA1 s.r. and s.l.m., respectively.
Our data indicated that fluoxetine did not induce structural nor
functional changes at perforant path-CA1 synapses. However,
consistent with our hypothesis, increased mushroom-type den-
dritic spines on proximal dendrites, where Schaffer collateral to
CA1 synapses occur in the s.r. were associated with a signifi-
cant reduction of LTP. Interestingly, LTD was also impaired at
these synapses. In addition, AMPA-R-dependent Ca2+ perme-
ability was decreased specifically in the s.r. along with increased
GluA2 content in AMPA-Rs.
MATERIALS AND METHODS
ANIMALS
Adult male Sprague–Dawley rats weighting 280–300 g (∼12
weeks old) at the beginning of the fluoxetine treatment were
used for all experiments. All procedures involving animals were
approved by the Universidad de los Andes Bioethical Committee
and were performed in accordance with the National Institute of
Health Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23). Either saline (0.9%NaCl, control group)
or 0.7mg/kg fluoxetine (Ely-Lilly Co., Indianapolis, USA) dis-
solved in saline was administered daily via i.p. injection between
9:00 and 10:00 AM for 28 days (flx 4 weeks). A second control
group of rats received a single fluoxetine injection (flx 24 h).
In total, 85 rats were sacrificed 24 h following the last
fluoxetine or saline injection to perform electrophysiological
recordings (n = 39), Golgi staining (n = 17), immunohisto-
chemistry (n = 12), and cobalt staining (n = 17). For immuno-
histochemistry or for Golgi staining, rats were sacrificed under
ketamine (50mg/kg) and xylazine (10mg/kg) anesthesia and then
perfused intracardially with saline followed by 300ml of 4%
paraformaldehyde in PBS.
EXTRACELLULAR FIELD RECORDINGS IN THE CA1 HIPPOCAMPAL
SUBFIELD
Recordings were performed in hippocampal slices, as previously
reported (Olmos et al., 2009). In each experimental group, 2–3
slices per rat were recorded. The animals were anesthetized with
halothane gas and then intracardially perfused with artificial cere-
brospinal fluid (aCSF, in mM; 124 NaCl; 5 KCl; 1.25 NaH2PO4;
1.0 MgCl2; 2.0 CaCl2; 26 NaHCO3; 10 glucose; pH 7.4). After per-
fusion, the animals were decapitated and brains rapidly removed,
immersed in ice-cold dissection buffer (in mM; 212.7 sucrose;
5 KCl; 1.25 NaH2PO4; 3 MgSO4; 1 CaCl2; 26 NaHCO3; 10
glucose; pH 7.4) and then the hippocampi dissected to obtain
transverse slices (400μm thickness) with a vibratome (Campden
Instruments, Leicester, UK). Slices were transferred to an inter-
face chamber containing aCSF saturated with 95% O2/5% CO2
at 36◦C, left at these conditions for 45min, and then main-
tained at 24◦C for 1 h. Single slices were transferred to a recording
chamber containing aCSF and continually perfused at a flow of
2ml/min.
Recording electrodes were glass micropipettes (1–3M) filled
with aCSF. For CA3-CA1 experiments, the concentric bipo-
lar stimulating electrode (FHC Corporate and Manufacturing,
Bowdoin, ME, USA) was placed on the Schaffer collateral fibers,
and the recording electrode into the s.r. of the CA1 region. For
input-output (I/O) experiments, increasing current steps from 0
to 500μA were applied. Averaged fiber volley amplitude vs. fEPSP
slope was plotted. For LTP experiments, stimuli able to elicit 50%
of the maximum fEPSP response were used for baseline record-
ings and theta burst stimulation (TBS). LTP was elicited after
20min of a stable baseline using electrical stimulation (constant
current, 200μs stimuli) delivered every 15 s. The TBS protocol
consisted of five stimuli trains with an inter-train interval of 10 s.
Each train consisted of 10 bursts at 5Hz, each burst having four
pulses at 100Hz. After TBS, potentiation was recorded for 1 h.
For LTD experiments, the stimulus intensity was adjusted to elicit
80% of the maximum response for baseline recordings and low
frequency stimulation (LFS). LTD was elicited after 20min of
a stable baseline using electrical stimulation (constant current,
200μs stimuli) delivered every 30 s. The LFS protocol to induce
LTD consisted of 1200 pulses at 2Hz and thereafter, data acquisi-
tion lasted 60min. To test the plasticity of the direct pathway from
the EC to CA1 synapses, the stimulation electrode was placed
on the temporoammonic pathway while recordings were per-
formed in the s.l.m. of the CA1 hippocampal area using the same
stimulation protocol as in Schaffer collateral-CA1 s.r. record-
ings (Remondes and Schuman, 2002), but in this case the aCSF
contained 4.0mM CaCl2. Hippocampal slices were mechanically
de-afferented from Schaffer collaterals.
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Voltage recordings were acquired using an extracellular
amplifier (Dagan Corporation, Minneapolis, MI, USA) and a
data acquisition board (National Instruments, USA) controlled
through Igor Pro software (Wavemetrics Inc., USA). LTP and LTD
plots were obtained by measuring the fEPSP slopes, considering
the baseline as 100%.
SPINE DENSITY AND MORPHOLOGY
Brains were processed using the FD Rapid GolgiStainTM kit (FD
Neuro Technologies, Baltimore, USA) and analyzed as already
described (Ampuero et al., 2007, 2010). Briefly, 11 selected pyra-
midal neurons of hippocampal layer CA1 were examined per
experimental condition. Proximal secondary dendrites in the s.r.
that emerged from the primary dendrite at <50μm away from
the soma were examined. Distal dendrites were at >150μm away
from the soma and corresponded to s.l.m. dendrites. It is known
that histological techniques lead to shrinkage due to fixation, pro-
cessing, dehydration, and mounting of samples. In our case, the
dentate gyrus was clearly visible at about 380μm away from the
pyramidal cell layer, indicating that at stretches between 200 and
350μm we are positioned in the s.l.m. In two cases, based on a
second criterion used to select s.l.m. dendrites: i.e., that s.r. pyra-
midal cell dendrites run perpendicular to the hippocampal fissure
while this perpendicular orientation is absent in s.l.m. (Pyapali
et al., 1998; Megias et al., 2001), selected dendrite stretches began
at ∼160μm away from the cell body. Spines were quantified
along segments of 50μm. Spine density was calculated as num-
ber of spines perμmand spine shape classification was performed
under the microscope at different focal planes into three groups:
(1) filopodia/thin, (2) stubby and (3) mushroom/branched. In
a few cases (less than 10%) in which spine category was not
clear to the observer, spine, and neck diameters were measured
at the focal plane in which the image appeared at its maximal size
and classified according to measures reported by Harris (Harris
et al., 1992). Photomicrographs for representative images were
captured with a ZeissAxioplan 2 microscope (100× objective,
numerical aperture 1.3) attached to a Nikon COOLPIX995 digital
camera (final magnification of 4700×).
IMMUNOSTAINING
Anti-GluA1 (1:50) and anti-GluA2 (1:400) from Millipore
(Temecula, CA, USA) for immunofluorescence and immuno-
histochemical staining were used. For immunofluorescence, the
secondary antibody Alexa Fluor® 488 conjugated to goat anti-
rabbit IgG (1:400) from Invitrogen (Eugene, OR, USA) was used.
Fluorescent images were obtained on a confocalmicroscope (LSM
510 Meta, Zeiss, USA; 20× magnification) using LSM 5 Pascal
software. For immunohistochemistry, primary antibodies were
detected with biotinylated anti-rabbit secondary antibody (1:200,
Jackson ImmunoResearch Laboratories, Inc., West Grove, PA,
USA) and 3,3-diaminobenzidine tetrahydrochloride (DAB) using
a nickel-intensified reaction according to the published protocol
(Ampuero et al., 2010). For quantification of immunochemical
staining, brain slices were visualized under a light microscope
(AxiosKop, Zeiss, Germany; 10× magnification; numeric aper-
ture 0.3), and images of serial sections were captured with a digital
camera (Nikon, CoolPIX 995) with a final magnification of 37×.
Digitized images were analyzed with the NIH ImageJ software.
Optical density of hippocampal s.r., s.l.m., and stratum pyrami-
dale (s.p.) layers in CA1 was analyzed from 3 to 5 sections per
animal restricted to bregma −3.14mm and bregma −4.52mm
and five consecutive areas of 47.3 ± 1.6μm2 were quantified. In
the case of the s.l.m., these areas were selected at 30–80μm away
from the hippocampal fissure, perpendicular toward the s.p. cell
layer.
COBALT STAINING
The Ca2+ permeability of GluA1-containing AMPARs was eval-
uated in fresh hippocampal sections using a modified cobalt
staining technique, adapted from Osswald et al. (2007). Briefly,
three to five slices per animal (n = 9 animals per condition)
were incubated with 5mM CoCl2 in assay buffer for 10min in
presence of a NMDA-R antagonist (40μM aminophosphono-
valerate, APV), a voltage-dependent Na+ channel blocker (1μM
tetrodotoxin), and a Ca2+ channel blocker (2μM Nimodipine).
The AMPA-R antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione
(20μM CNQX), was added to negative controls. Sections were
incubated with the AMPA-R agonist quiscualic acid (100μM)
for 20min. Intracellular Co2+ was precipitated with 0.24%
ammonium sulfide, and slices were fixed in 0.8% glutaralde-
hyde. Silver enhancement of the Co2+ sulfide precipitate was
obtained with AgNO3. Photomicrographs of hippocampal sec-
tions were captured with a stereoscopic microscope attached to
a Nikon COOLPIX995 digital camera at a final magnification of
3.74×. For each hippocampal digital image, the dorsal-most CA1
subfield was selected and the mean optical density of 114.0 ×
28.5μm (3250μm2) rectangles was calculated for each layer, i.e.,
s.p., s.l.m., and s.r., and using NIH ImageJ software.
STATISTICAL ANALYSIS
The GraphPad PRISM 4.0 software was used to analyze data. Data
are presented as mean ± SEM. For morphological and optical
density analysis, the Mann-Whitney U-test was applied. In the
electrophysiological experiments n-value represents the mean of
2–3 slices per rat per condition. For input/output curves, data
from each experimental group was fit to a linear regression and
compared using covariate analysis. LTP and LTD data was sub-
jected to one-way analysis of variance (ANOVA), followed by a
Bonferroni post-hoc test.
RESULTS
FLUOXETINE INDUCED CHANGES IN SPINE DENSITY AND
MUSHROOM-TYPE MORPHOLOGY IN THE CA1 s.r., BUT NOT
IN THE s.l.m.
In order to examine the morphology of the post-synaptic com-
partment in CA1, i.e., dendritic spines, the Golgi staining method
was used. Spine morphology and spine density of secondary den-
drites was analyzed at proximal segments emerging<50μmaway
from the soma of hippocampal CA1 neurons (Figure 1A). Spine
density (spines/μm) increased significantly from 1.59 ± 0.11 to
1.92 ± 0.07 after 4 weeks of fluoxetine treatment (p < 0.05). This
increase was accompanied by a higher proportion of mushroom-
type spines (saline: 26.2 ± 1.7%; fluoxetine: 39.6 ± 1.8%, p <
0.001) and a concomitant decrease of thin (saline: 30.7 ± 1.4%;
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FIGURE 1 | Long-term fluoxetine treatment induces morphological
changes in proximal dendritic spines of CA1 pyramidal neurons.
(A) Left: A representative image of a Golgi stained neuron from a
fluoxetine-treated rat. CA1 stratum radiatum (s.r.) subfield was chosen for
analysis. Scale bar: 50μm. Right: representative dendritic segments of
saline and fluoxetine-treated rats under larger amplification. Scale bar:
10μm. (B) The selected dendritic segments in (A) (right panels) are
shown with identified spine types: filopodia/thin (T), stubby (S), and
mushroom/branched (M). The asterisks indicate two superimposed M-type
spines that were resolved by observation at different focal planes. Bar
graphs show spine density and the abundance of spines in each of the
three shape categories. Results are presented as mean ± SEM and were
determined from 11 cells per condition, obtained from eight saline (total
spines, 874)- and nine fluoxetine (total spines, 957)-treated rats. Data were
statistically evaluated with the Mann–Whitney U-test, ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
fluoxetine: 26.1 ± 1.4%; p < 0.05) and stubby spines (saline:
43.1 ± 2.3%; fluoxetine: 34.3 ± 1.1%; p < 0.01) (Figure 1B).
These observations indicated that repetitive fluoxetine adminis-
tration induced synaptogenesis and synapse maturation in the
hippocampal CA1 s.r., similarly to those reported in some cere-
brocortical regions (Ampuero et al., 2010). To test whether
changes in spine morphology extended to distal dendrites, spine
density and shape were quantified on secondary dendrites emerg-
ing at distances farther than 150μm away from the cell soma,
located in the s.l.m. (Figure 2A). In contrast to the previous
findings, no change in spine density nor in the proportion ofmor-
phological sub-types were found within the CA1 s.l.m. subfield
(Figure 2B).
LONG-TERM FLUOXETINE TREATMENT INCREASED EXCITABILITY AT
SCHAFFER COLLATERAL-CA1 SYNAPSES, BUT IMPAIRED LTP AND LTD
To compare the effect of repetitive fluoxetine on basal neurotrans-
mission and activity-dependent synaptic plasticity at CA3-CA1
synapses, we compared treated animals to two control groups:
saline-treated rats and rats exposed to a single fluoxetine injec-
tion. Therefore, a direct effect of fluoxetine could be discarded.
Stimulus-evoked fEPSPs were recorded at the CA1 s.r. after
Schaffer collateral stimulation (Figure 3A). First, post-synaptic
excitability was tested by I/O curves, in which the fEPSP slopes
were measured in response to single electrical stimuli of increas-
ing magnitude. Significantly higher fEPSP slopes were recorded
after 28 days of fluoxetine treatment, as compared to both control
groups (Figure 3B).
Application of the TBS protocol, which is capable of inducing
robust LTP in saline-treated animals, was not able to induce LTP
nor LTD in rats chronically treated with fluoxetine. In Figure 3C,
representative recordings are shown. The mean % of fEPSP
slopes, ranging from 45 to 60min after the TBS, were pooled for
analysis (saline: 161.3 ± 10.8%; fluoxetine 24 h: 147.7 ± 6.7%;
fluoxetine 4 weeks: 110.7 ± 2.4%; F(2, 14) = 16.04, p < 0.001;
Figure 3D). A single fluoxetine injection did not interfere with
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FIGURE 2 | Long-term fluoxetine treatment does not affect distal
dendritic spine morphology of CA1 pyramidal neurons. (A) Left: Golgi
stained CA1 pyramidal neuron indicating the stratum lacunosum moleculare
(s.l.m.) where the morphological analysis was performed. #At this level can
be observed granule neuron dendrites coming from dentate gyrus. Scale
bar: 100μm. Right: representative dendritic segments of saline and
fluoxetine-treated rats under larger amplification. Scale bar: 10μm. (B) The
number of spines and the morphology of spines were analyzed and plotted
as spine density and % of spine type, respectively. Filopodia/thin (T), stubby
(S), and mushroom/branched (M) shape categories are shown. Results are
presented as mean ± SEM and were determined from 10 to 11 cells per
condition, obtained from five saline (total spines, 979)- and six fluoxetine
(total spines, 942)-treated rats. Data were not statistically significant after a
Mann–Whitney U-test analysis.
LTP induction. A similar analysis of the LTD data revealed that
LTD was blocked after repetitive fluoxetine treatment, but not
after a single fluoxetine dose (saline: 77.5 ± 2.4%; fluoxetine 24 h:
71.0 ± 3.7%; fluoxetine 4 weeks: 101.3 ± 1.0%, F(2, 11) = 46.23,
p < 0.0001; Figure 3E). These results revealed that long-term
fluoxetine, able to induce morphological changes in the post-
synaptic compartment, induced deficits in activity-dependent
plasticity. In turn, the increased excitability observed at CA3-CA1
synapses can be due to increased spine density and/or the fact that
large spines are known to generate a larger postsynaptic responses
(Spruston, 2008).
To further clarify whether the detrimental effects of fluoxetine
on LTP and LTD were associated with the changes in spine mor-
phology and density, electrophysiological recordings at perforant
path-CA1 synapses were performed.
LONG-TERM FLUOXETINE TREATMENT DID NOT AFFECT LTP NOR LTD
AT PERFORANT PATH-CA1 SYNAPSES
Stimulus-evoked fEPSPs were recorded at the CA1 s.l.m. after
temporoammonic pathway stimulation (Figure 4A). No sig-
nificant differences in fEPSP slopes were observed between
saline- and fluoxetine-treated rats after 28 days of adminis-
tration (saline: 0.3773 ± 0.1753; fluoxetine 4 weeks: 0.3838 ±
0.1335, p = 0.997; Figure 4B). LTP or LTD were induced in these
synapses after TBS or LFS stimulation, respectively, in slices from
saline- and repetitively fluoxetine-treated rats. In Figures 4C and
D, representative recordings are shown. The mean % of fEPSP
slopes, ranging from 45 to 60min, indicated that both groups
had similar LTP and LTD responses (LTP, saline: 166 ± 8.2%;
fluoxetine 4 weeks: 136 ± 11.6%, p = 0.143; LTD, saline: 64.5 ±
6.8%; fluoxetine 4 weeks: 59 ± 4.6%, p = 0.519; Figures 4E and
F). As mushroom-type spines are enriched in Ca2+ imperme-
able GluA2-containing AMPA-Rs and as such, should contribute
to limited plasticity observed in the CA1 s.r., where changes in
spine morphology had been detected along with LTP and LTD
impairment (Isaac et al., 2007; Medvedev et al., 2008).
LONG-TERM FLUOXETINE TREATMENT INCREASED
GluA2-CONTAINING AMPA-Rs IN THE CA1 s.r. SUBFIELD
Immunofluorescent labeling of GluA1 and GluA2 subunits was
performed in brain sections after 4 weeks of either saline or fluox-
etine administration. Confocal images revealed decreased GluA1,
but enhanced GluA2 levels in the CA1 s.r. subfield following flu-
oxetine treatment (Figure 5A). To quantify the relative content of
these subunits in hippocampal subfields, immunohistochemical
staining was performed. The relative staining intensity compared
to the s.p. in the s.r. and in the s.l.m. was assessed. While GluA1
staining did not change in neither of the subfields, increased
GluA2 immunoreactivity was found in the s.r. of fluoxetine-
treated rats (Figure 5B, 0.82 ± 0.04 vs. 1.01 ± 0.05; p < 0.05).
In contrast, no staining difference was found in the s.l.m. (not
shown, 1.13 ± 0.1 vs. 1.14± 0.08, n = 5). Interestingly, as already
reported, these data revealed an increased AMPA-R subunit stain-
ing in the control situation in the s.l.m. when compared to the s.r.
(0.82 ± 0.04 vs. 1.13 ± 0.1; p < 0.05) (Nicholson et al., 2006).
To further explore a higher GluA2 over GluA1 content at the
functional level, the AMPA-R Ca2+-permeability was assessed
by using the cobalt staining protocol (Figure 6). AMPA-Rs were
stimulated with quisqualic acid while other Ca2+ influx pathways
were pharmacologically blocked. After repetitive fluoxetine treat-
ment, higher cobalt staining in the CA1 s.p. (saline: 100.3 ± 6.2%,
fluoxetine: 169.9 ± 8.9%; p < 0.001) was found while the stain-
ing intensity in the CA1 s.r. (saline: 164.0 ± 10.1%, fluoxetine:
130.6 ± 7.5%; p < 0.05) decreased. No differences were found
among experimental groups in the s.l.m. (not shown, 168 ± 16%
vs. 163 ± 17%). All together, these results indicate that GluA2
is up-regulated in the s.r. while no staining differences could be
detected in the s.l.m.
DISCUSSION
The main finding of the present work is that repetitive, but not
a single, administration of low and clinically relevant doses of
fluoxetine to naïve rats enhanced the excitability of CA1 neu-
rons, but impaired activity-dependent plasticity at hippocampal
CA1 synapses in an input-specific manner. This impairment
was associated to a selective increase of spine density and to a
higher proportion of mushroom-type spines, restricted to the
proximal dendritic segment of CA1 pyramidal cells that receives
the Schaffer collateral input. At the molecular level, changes
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FIGURE 3 | Four weeks of fluoxetine administration affects basal
synaptic transmission and synaptic plasticity at CA3-CA1 synapses.
Experiments were performed in slices from saline (sal), single (flx 24 h), and
repeated (flx 4 weeks) fluoxetine treatment groups. (A) The diagram shows
the stimulating electrode inserted into Schaffer collaterals (SC) and the
recording electrode placed in the CA1 s.r. (B) Input/output curves. The fEPSP
slopes vs. increasing presynaptic fiber volley (FV) amplitudes were plotted.
Data were fit to a linear regression and compared using covariate analysis.
The slope obtained in repetitive fluoxetine-treated rats (0.48 ± 0.05,
r2 = 0.99) was significantly different (p < 0.01) compared to saline-treated
rats (0.23 ± 0.04, r2 = 0.99) or to rats treated with fluoxetine only once
(0.23 ± 0.05, r2 = 0.97). Saline, n = 6 (17 slices); fluoxetine 24h, n = 6
(14 slices); fluoxetine 4 weeks, n = 8 (20 slices). (C) Representative traces of
extracellular field recordings are shown before and after LTP (upper panels) or
LTD (lower panels) induction. (D) Long-term potentiation (LTP) induced by
theta burst stimulation (TBS) and (E) long-term depression (LTD) induced by
low frequency stimulation (LFS) were blocked in hippocampal slices of rats
treated for 4 weeks with fluoxetine. Bar graphs represent the mean %
change in fEPSP slopes compared to baseline, from 45 to 60min after LTP
(D inset) or LTD induction (E inset). LTP: sal, n = 4 (14 slices); flx 4 weeks,
n = 6 (14 slices); flx 24 h, n = 6 (12 slices). LTD: sal, n = 4 (12 slices); flx 4
weeks, n = 5 (15 slices); flx 24 h, n = 4 (9 slices). Data from D and E were
statistically evaluated by one-way ANOVA, followed by a Bonferroni post hoc
test. ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 4 | Four weeks of fluoxetine administration does not affect
synaptic plasticity at perforant pathway-CA1 synapses. Experiments
were performed in slices from saline- (sal) and fluoxetine- (flx 4 weeks)
treated rats. (A) The diagram shows the stimulating electrode inserted into
the temporoammonic pathway (TA) and the recording electrode in the CA1
s.l.m. EC, entorhinal cortex. The dashed line indicates the place of the
physical de-afferentation of Schaffer collateral inputs to CA1. (B) The fEPSP
slopes vs. increasing presynaptic fiber volley (FV) amplitudes were plotted to
analyze the input/output curves. No significant difference between saline-
and repetitive fluoxetine-treated rats was found after data were fit to a linear
regression and compared using covariate analysis. Saline, n = 5 (12 slices);
fluoxetine 4 weeks, n = 8 (19 slices). (C,D) Sample traces of extracellular
field recordings are shown before and after LTP (E) or LTD (F) induction.
(E) Long-term potentiation (LTP) induced by theta burst stimulation (TBS)
were unaffected after perforant pathway stimulation. No significant difference
was found when the mean fEPSP integrated between 45 and 60min after
LTP induction was compared (p = 0.143; unpaired t-test). LTP: sal, n = 3
(8 slices); flx 4 weeks, n = 3 (6 slices). (F) Similar LTD was also induced by
low frequency stimulation (LFS) of the perforant path in slices from saline-
and fluoxetine-treated animals (p = 0.519; unpaired t-test).
in AMPA-R stoichiometry in the s.r. might contribute to the
described effect. An increased GluA2 over GluA1 content in
AMPA-Rs, associated with enhanced dendritic spine density was
reported previously in the telencephalon by western blots of
immunoprecipitated receptor subunits from postsynaptic densi-
ties and in isolated synaptosomes. In turn, immunohistochem-
istry and morphological analysis revealed that changes were
restricted to some neocortical regions, while the hippocampus,
with its well-defined cellular layers and dendritic sub-regions,
was not analyzed (Ampuero et al., 2010). To now explore a
functional implication of such molecular and morphological
adaptations, we took advantage of the well-characterized activity-
dependent cellular plasticity paradigms in the hippocampal CA1
region.
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FIGURE 5 | GluA1 and GluA2 were detected in the CA1 region by
immunofluorescence and immunohistochemical staining. (A)
Fluorescence images of GluA1 and GluA2 immunostainings reveal a change
in the distribution of subunits between the cell soma (s.p.) and dendritic
(s.r.) compartments. (B) Relative staining intensity (s.r./s.p.) of
immunohistochemical GluA1 and GluA2 stainings revealed higher GluA2
intensity in the s.r. of fluoxetine-treated rats (∗p < 0.05, n = 5 − 7, Student
t-test). s.r., stratum radiatum; s.p., stratum pyramidale. Scale bars: 50μm.
HOMEOSTATIC SYNAPTIC ADAPTATIONS AT THE CA1 HIPPOCAMPAL
SUBFIELD ARE POSSIBLY INDUCED BY LONG-TERM FLUOXETINE
TREATMENT
The CA1 hippocampal region is densely innervated by serotonin-
ergic fibers originating in the dorsal raphe nuclei (Jacobs and
Azmitia, 1992), which regulate excitability and synaptic trans-
mission via activation of a large range of receptor subtypes.
An enhanced serotonin-mediated synaptic response is caused by
5-HT7 and 5-HT4 receptors (Torres et al., 1995; Costa et al.,
2011), while 5-HT1A and 5-HT1B activation results in hyper-
polarization and, hence, decreased excitability (Andrade and
Chaput, 1991; Mlinar et al., 2003). Interestingly, the integration
of excitatory and inhibitory serotonin inputs resulted in global
inhibition of CA1 neurons that could be observed either fol-
lowing activation of the raphe nuclei in vivo (Segal, 1975) or
after local serotonin application (Otmakhova and Lisman, 2000;
Otmakhova et al., 2005), supporting the idea of a homeostatic
up-scaling induced by long-term elevation of serotonin levels
(Turrigiano et al., 1998). Therefore, serotonin-mediated tonic
inhibition of glutamatergic CA1 pyramidal neurons could trig-
ger an adaptive homeostatic response leading to enhanced basal
neurotransmission and dendritic spine remodeling (Turrigiano,
1999). However, how this remodeling can be performed in a dif-
ferential manner along the dendritic tree is presently unknown.
A differential serotoninergic innervation of s.l.m. dendrites com-
pared to the s.r. dendrites as well as possible serotonin receptor
subtype gradients might contribute to such effects (Moore and
Halaris, 1975; Oleskevich and Descarries, 1990). Gradients of
intrinsic membrane conductances and of glutamate receptors
along the dendritic tree in the CA1 region will also influence
post-synaptic responses and activity-dependent plasticity (Nolan
et al., 2004; Nicholson et al., 2006; Camp, 2012). In addition,
the mechanisms that contribute to plasticity are differentially
expressed along both afferent pathways that contact CA1 api-
cal dendrites: while an enhancement of pre-synaptic glutamate
release contributes to perforant path-CA1 LTP, this does not occur
at CA3-CA1 LTP (Ahmed and Siegelbaum, 2009), although both
are NMDA-R dependent. A similar effect of fluoxetine on spine
morphology in the CA1 s.r. had already been described (Hajszan
et al., 2005), however, the CA1 s.l.m. was not analyzed nor input-
specific electrophysiological recordings were performed. The fact
that LTP was unaffected in the direct perforant pathway input to
the CA1 region, at least until 60min after induction, favors the
idea that the deficit in synaptic plasticity at CA3-CA1 synapses
was associated to changes in postsynaptic spine morphology, i.e.,
that stronger and more “mature” synapses negatively affected
further activity-dependent plasticity at CA3-CA1 synapses.
PARTICIPATION OF AMPA-Rs IN FLUOXETINE-INDUCED EFFECTS
In agreement with a homeostatic-like synaptic re-organization
induced by inhibitory-acting serotonin, synaptic scaling following
the blockade of network activity is mediated by an accumula-
tion of GluA2-containing AMPA-Rs (Gainey et al., 2009). In
such a way, Ca2+ entry is abolished in AMPA-Rs containing
solely GluA2 (Traynelis et al., 2010). Moreover, GluA2 defi-
cient mice exhibited increased Ca2+ permeability and enhanced
LTP (Jia et al., 1996). Therefore, the increase of GluA2 stain-
ing in dendrites is consistent with the data obtained with cobalt
measurements assessing Ca2+ permeability. It had been shown
that repetitive fluoxetine treatment increased the expression of
AMPA-R subunits in the forebrain, including the prefrontal cor-
tex and hippocampus (Ampuero et al., 2010; Barbon et al., 2011).
However, the fact that GluA2 staining and Ca2+ permeability was
increased and decreased, respectively, in the s.r. is in line with
the change in fluoxetine-induced AMPA-R subunit composition
reported to occur in isolated synaptic fractions derived from the
whole forebrain (Ampuero et al., 2010). Thus, reduced AMPA-R
dependent Ca2+ influx in CA1 dendrites could contribute to the
impairment in activity-dependent plasticity. The participation of
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FIGURE 6 | Long-term fluoxetine administration decreased
Ca2+-permeable AMPA-Rs in the CA1 stratum radiatum (s.r.).
Hippocampal slices from saline- (sal) and fluoxetine- (flx) treated
rats were stimulated with 100μM quisqualic acid (QA) to detect
Co2+ uptake. The AMPA-R blocker CNQX (20μM) was used as a
negative control (QA+CNQX). (A) Hippocampal sections are shown
in each experimental condition. Bar: 500μm. (B) Increased
magnification was used to quantify relative staining in the two
CA1 subfields: stratum pyramidale (s.p.) and s.r. Bar: 50μm.
Bar graphs: the mean optical density was plotted. Data were
statistically evaluated with the Mann–Whitney U-test, ∗p < 0.05,
∗∗∗p < 0.001. (n = 9 group).
other Ca2+-permeable ion channels, e.g., NMDA-Rs and voltage-
sensitive Ca2+-channels, cannot be excluded. Interestingly, it has
been shown that the latter can regulate Ca2+ influx into dendritic
spines in a homeostatic manner (Yasuda et al., 2003). Moreover,
along with a change in AMPA-R subunit composition, fluoxetine
also induces a switch toward GluN2A-rich NMDA-Rs (Ampuero
et al., 2010), which are characterized by a reduced Ca2+ influx
when compared to GluN2B subunit-containing receptors.
The prevailing view regarding the participation of AMPA-R
subunits in LTP and LTD establishes that GluA1 subunits become
inserted or endocytosed to the synapse in an activity depen-
dent manner while GluA2/GluA3 subunits traffic constitutively.
Double GluA2/3 knockout animals continue to express LTP and
LTD (Meng et al., 2003), while GluA1 availability and traffick-
ing is required for early expression of LTP and LTD (Derkach
et al., 2007). Recent findings indicate that LTP depends more
importantly on the presence of an AMPA-R reserve pool than on
specific subunits (Granger et al., 2013). Taken together, the effect
of fluoxetine could be due to a deficiency in GluA1 subunit traf-
ficking and/or membrane insertion leading to a relative lack of
extra-synaptic AMPA-Rs.
EFFECT OF FLUOXETINE ON PLASTICITY PARADIGMS
Our study revealed that 28 days of fluoxetine impaired activity-
dependent plasticity that was associated with changes in spine
morphology. This is in opposition to two previous studies which
reported that fluoxetine restored developmental- or juvenile-like
plasticity in the visual cortex or lateral amygdala, respectively, in
adult rodents (Maya Vetencourt et al., 2008; Karpova et al., 2011).
In the first study, Maya Vetencourt et al. used a similar treat-
ment duration and doses, although the rat strain was different
(Maya Vetencourt et al., 2008). In the second study, Karpova et al.
administered fluoxetine to juvenile mice (P42) at a 14-fold higher
dose for 3 weeks (Karpova et al., 2011). Therefore, differences in
the age of animals, treatment duration, examined brain area, as
well in the strains of rats or rodent species used may critically
influence the outcomes of the experiments. Especially differences
in the density of serotoninergic innervation and in the expression
of serotonin receptor subtypes might define the consequences
of fluoxetine-induced serotonin elevation. Indeed, the apparent
contradictory effect of repetitive fluoxetine on LTP (i.e., facilita-
tor in the lateral amygdala but blocker in the CA s.r.) might be
explained by the differential effect of serotonin in these regions.
While serotonin activated excitatory principal neurons of the lat-
eral amygdala by enhancing depolarization through 5-HT2 recep-
tors (Yamamoto et al., 2012), it activated inhibitory interneurons
in the hippocampal CA1 subfield (Shen and Andrade, 1998)
and acted on inhibitory receptors expressed by CA1 pyramidal
neurons. In the visual cortex, reduced intra-cortical inhibition
was associated with the effect of chronic fluoxetine treatment on
restoration of LTP in the visual cortex (Maya Vetencourt et al.,
2008). The role of the inhibitory tone at CA3-CA1 synapses was
not tested in the present study.
Another study showed that repeated fluoxetine administration
using a dose of 1mg/kg, close to the dose used by us, reduced
LTP at perforant path-dentate gyrus synapses (Stewart and Reid,
2000). The idea that in the CA1 region serotonin inhibited LTP
was discussed in a previous in vivo study, in which acute flu-
oxetine administration (10mg/kg, i.p., 40min prior to Schaffer
collateral stimulation) increased serotonin levels, which, in turn,
blocked CA1 LTP (Shakesby et al., 2002). This blocking effect
could be ascribed to immediate elevation of serotonin, while a
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single fluoxetine administration, even at higher doses, should not
lead to maintained high serotonin levels 24 h after the injection
(Caccia et al., 1990). This suggested that the effect we observed
after 4 weeks of administration, but measured 24 after the last
dose, was a consequence of adaptive plastic changes that required
repeated fluoxetine administration, and not to acute changes in
serotonin. Consistent with our data, it was shown that repeated
administration of methamphetamine, a drug that acts on central
monoamine neurotransmission, including the serotonin system,
enhanced basal neurotransmission and had a detrimental effect
on CA3-CA1 synaptic plasticity (Swant et al., 2010).
The increased fEPSPs revealed in I/O curves in fluoxetine-
treated animals could be due to direct effects of fluoxetine on
glutamate receptors. However, fluoxetine has inhibitory effects on
AMPA and NMDA receptors (Szasz et al., 2007; Kim et al., 2013)
and therefore, decreased fEPSPs should be expected. In conse-
quence, the most straightforward explanation is that larger spines
are able to elicit larger post-synaptic responses. This could be
mediated by several plasticity-related signals that are expressed
following fluoxetine treatment, such as BDNF (Castren, 2005;
Bath et al., 2012) or IGF-1 (Corvin et al., 2012), which in turn
are able to stimulate glutamate receptor expression and recep-
tor phosphorylation (Slack et al., 2004; First et al., 2011). A
changed inhibition due to serotonin-induced re-arrangements of
interneurons can also contribute to this phenomenon (Mendez
et al., 2012).
The concept of meta-plasticity posits that synapses that have
previously been potentiated are more likely to express LTD and
less likely to express LTP, whereas the opposite applies if LTD has
been previously induced (Bear, 2003). It is therefore difficult to
reconcile that both plasticity paradigms are impaired under the
used experimental conditions. If LTP is occluded due to a synap-
tic up-scaling at CA3-CA1 synapses, LTD should be enhanced, but
not decreased, at these synapses. We therefore propose that Ca2+-
influx pathways and/or Ca2+ changes in dendritic spines caused
by intracellular release or changes in buffering capacity, might be
altered thereby affecting both plasticity paradigms. Further exper-
iments, using different stimulation protocols, increasing extra-
cellular Ca2+ concentration or blocking inhibitory interneurons
need to be performed to get insight into underlying mechanisms.
However, it is clear that maintaining the stimulation conditions
of the control group in fluoxetine-treated animals, both LTP and
LTD are impaired. Similarly, a specific stimulation protocol and
learning procedures can lead to occlusion of both LTP and LTD
(Liang et al., 2002; Delvendahl et al., 2010), as we found in
fluoxetine-treated animals.
In agreement with our findings, chronic escitalopram treat-
ment inhibited CA3-CA1 LTP in healthy rats in a stress-resistant
strain (Flinders Resistant Line rats, Karolinska Institutet). This
phenomenon was attenuated after exposure to stress (Ryan et al.,
2009), thereby confirming a distinct result in naïve subjects.
Although the effect of fluoxetine described by usmay be restricted
to non-stressed or non-depressed subjects, we report that repeti-
tive treatment impacts significantly glutamate neurotransmission
and plasticity in the hippocampus.
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